Making good on its threat, Eli Lilly has begun eliminating mandated price breaks to a few dozen hospitals that participate in ...

This week on "The Readout LOUD" podcast: new hope in treating Huntington's disease and a report card on RFK Jr.'s promises.

A wide gap exists between what Patrick Soon-Shiong says his cancer drugs can achieve and what they actually do, STAT's Adam ...

GLP-1 weight loss drugs like Novo Nordisk’s Wegovy and Eli Lilly’s Zepbound have been on the market for a few years now. The ...

Here in the U.S., infant formula has a good overall safety record. But the stakes are incredibly high if something goes wrong ...

A new infant botulism outbreak puts fancy formulas that position their products as safer than other options under scrutiny.

Nursing home residents who received at least one dose of shingles vaccine were 24 percent less likely to develop dementia, a ...

Washington’s vaccine wars are escalating again as Senate Democrats seek to build a paper trail around Health Secretary Robert ...

AI is creating a new and largely overlooked strain on something fundamental to health,” write Sten H. Vermund and Patricia J.

Improving global health should be a top policy priority of the United States,” write Anand Parekh, Tom Daschle, and Bill ...

Senate Democrats open an inquiry into the Trump administration’s remaking of U.S. vaccine policy, demanding officials produce ...

Bob covers the money in health care, focusing on health insurance and hospitals. His stories delve into Medicare Advantage, opaque prescription drug benefits, and how much executives actually make. He ...